Miguel A. Sanz
Hospital Universitario La Fe
Servicio de Hematologia
Valencia
Spain
Name/email consistency: high
- Analysis of EQ-5D scores from two phase 3 clinical trials of romiplostim in the treatment of immune thrombocytopenia (ITP). Sanz, M.A., Aledort, L., Mathias, S.D., Wang, X., Isitt, J.J. Value. Health (2011)
- Modern approaches to treating acute promyelocytic leukemia. Sanz, M.A., Lo-Coco, F. J. Clin. Oncol. (2011)
- Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome. Sanz, M.A., Montesinos, P., Rayón, C., Holowiecka, A., de la Serna, J., Milone, G., de Lisa, E., Brunet, S., Rubio, V., Ribera, J.M., Rivas, C., Krsnik, I., Bergua, J., González, J., Díaz-Mediavilla, J., Rojas, R., Manso, F., Ossenkoppele, G., González, J.D., Lowenberg, B. Blood (2010)
- Open issues on bleeding and thrombosis in acute promyelocytic leukemia. Sanz, M.A., Montesinos, P. Thromb. Res. (2010)
- Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Sanz, M.A., Grimwade, D., Tallman, M.S., Lowenberg, B., Fenaux, P., Estey, E.H., Naoe, T., Lengfelder, E., Büchner, T., Döhner, H., Burnett, A.K., Lo-Coco, F. Blood (2009)
- FLT3 inhibition as a targeted therapy for acute myeloid leukemia. Sanz, M., Burnett, A., Lo-Coco, F., Löwenberg, B. Curr. Opin. Oncol (2009)
- Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group. Sanz, M.A., Montesinos, P., Vellenga, E., Rayón, C., de la Serna, J., Parody, R., Bergua, J.M., León, A., Negri, S., González, M., Rivas, C., Esteve, J., Milone, G., González, J.D., Amutio, E., Brunet, S., García-Laraña, J., Colomer, D., Calasanz, M.J., Chillón, C., Barragán, E., Bolufer, P., Lowenberg, B. Blood (2008)
- Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation. Sanz, M.A., Labopin, M., Gorin, N.C., de la Rubia, J., Arcese, W., Meloni, G., Bacigalupo, A., Alessandrino, P., Carreras, E., Iriondo, A., Novitzky, N., Jacobs, P., Bandini, G., Lo-Coco, F., Frassoni, F., Rocha, V. Bone Marrow Transplant. (2007)
- Treatment of acute promyelocytic leukemia. Sanz, M.A. Hematology. Am. Soc. Hematol. Educ. Program (2006)
- Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia. Sanz, M.A., Tallman, M.S., Lo-Coco, F. Blood (2005)
- Standard practice and controversial issues in front-line therapy of acute promyelocytic leukemia. Sanz, M.A., Lo Coco, F. Haematologica (2005)
- Arsenic trioxide in the treatment of acute promyelocytic leukemia. A review of current evidence. Sanz, M.A., Fenaux, P., Lo Coco, F. Haematologica (2005)
- Practice points, consensus, and controversial issues in the management of patients with newly diagnosed acute promyelocytic leukemia. Sanz, M.A., Tallman, M.S., Lo-Coco, F. Oncologist (2005)
- Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group. Sanz, M.A., Martín, G., González, M., León, A., Rayón, C., Rivas, C., Colomer, D., Amutio, E., Capote, F.J., Milone, G.A., De La Serna, J., Román, J., Barragán, E., Bergua, J., Escoda, L., Parody, R., Negri, S., Calasanz, M.J., Bolufer, P. Blood (2004)
- All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia. Sanz, M.A., Vellenga, E., Rayón, C., Díaz-Mediavilla, J., Rivas, C., Amutio, E., Arias, J., Debén, G., Novo, A., Bergua, J., de la Serna, J., Bueno, J., Negri, S., Beltrán de Heredia, J.M., Martín, G. Blood (2004)
- Choice of chemotherapy in induction, consolidation and maintenance in acute promyelocytic leukaemia. Sanz, M.A., Martín, G., Lo Coco, F. Best. Pract. Res. Clin. Haematol (2003)
- Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial. Sanz, M.A., López, J., Lahuerta, J.J., Rovira, M., Batlle, M., Pérez, C., Vázquez, L., Julià, A., Palau, J., Gutiérrez, M., Capote, F.J., Ramos, F., Benlloch, L., Larrea, L., Jarque, I. J. Antimicrob. Chemother. (2002)
- Cutaneous promyelocytic sarcoma at sites of vascular access and marrow aspiration. A characteristic localization of chloromas in acute promyelocytic leukemia?. Sanz, M.A., Larrea, L., Sanz, G., Martín, G., Sempere, A., Gomis, F., Martínez, J., Regadera, A., Saavedra, S., Jarque, I., Jiménez, C., Cervera, J., de La Rubia, J. Haematologica (2000)
- Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Sanz, M.A., Lo Coco, F., Martín, G., Avvisati, G., Rayón, C., Barbui, T., Díaz-Mediavilla, J., Fioritoni, G., González, J.D., Liso, V., Esteve, J., Ferrara, F., Bolufer, P., Bernasconi, C., Gonzalez, M., Rodeghiero, F., Colomer, D., Petti, M.C., Ribera, J.M., Mandelli, F. Blood (2000)
- A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group. Sanz, M.A., Martín, G., Rayón, C., Esteve, J., González, M., Díaz-Mediavilla, J., Bolufer, P., Barragán, E., Terol, M.J., González, J.D., Colomer, D., Chillón, C., Rivas, C., Gómez, T., Ribera, J.M., Bornstein, R., Román, J., Calasanz, M.J., Arias, J., Alvarez, C., Ramos, F., Debén, G. Blood (1999)
